GSK shares dropped by the most in nearly two years after a ruling by the Delaware State Court that will allow jury trials in cases brought by cancer sufferers who say the heartburn drug Zantac caused their condition.
French bond yields were steady on Monday after the country’s rating was lowered one notch by S&P Global Ratings, as the rating agency lifted its budget deficit estimate.